Cp-751,871


Indications and Reactions:

Role Indications Reactions
Primary
Breast Cancer 30.3%
Hypertension 11.0%
Non-small Cell Lung Cancer 9.7%
Prophylaxis 9.0%
Pain 6.9%
Hypercholesterolaemia 5.5%
Breast Cancer Metastatic 2.8%
Pancreatic Carcinoma Metastatic 2.8%
Supportive Care 2.8%
Cough 2.1%
Decreased Appetite 2.1%
Diarrhoea 2.1%
Dyspepsia 2.1%
Hypothyroidism 2.1%
Nausea 2.1%
Anxiety 1.4%
Asthma 1.4%
Constipation 1.4%
Dyspnoea 1.4%
House Dust Allergy 1.4%
Aphasia 13.0%
Grand Mal Convulsion 13.0%
Death 8.7%
Febrile Neutropenia 8.7%
Gastrointestinal Infection 8.7%
Urinary Tract Infection 8.7%
Cerebrovascular Accident 4.3%
Confusional State 4.3%
Disease Progression 4.3%
Dysarthria 4.3%
Epilepsy 4.3%
Non-small Cell Lung Cancer 4.3%
Pneumonia 4.3%
Pneumonitis 4.3%
Vomiting 4.3%
Secondary
Non-small Cell Lung Cancer 48.2%
Breast Cancer 8.2%
Pain 7.8%
Prostate Cancer 6.1%
Non-small Cell Lung Cancer Stage Iv 4.3%
Vomiting 3.6%
Hypertension 3.5%
Nausea 2.7%
Breakthrough Pain 1.8%
Cough 1.7%
Constipation 1.6%
Prostate Cancer Metastatic 1.4%
Dyspepsia 1.3%
Prophylaxis Of Nausea And Vomiting 1.3%
Diabetes Mellitus 1.2%
Supplementation Therapy 1.2%
Anxiety 1.1%
Ewing's Sarcoma 1.0%
Gout 1.0%
Premedication 1.0%
Pneumonia 13.2%
Dyspnoea 10.1%
Death 7.8%
Hyperglycaemia 7.0%
Vomiting 7.0%
Hyponatraemia 6.2%
Renal Failure Acute 6.2%
Urinary Tract Infection 4.7%
White Blood Cell Count Decreased 4.7%
Pneumomediastinum 3.9%
Pulmonary Embolism 3.9%
Diverticulitis 3.1%
Mucosal Inflammation 3.1%
Myocardial Ischaemia 3.1%
Sensory Loss 3.1%
Sepsis 3.1%
Upper Gastrointestinal Haemorrhage 3.1%
Cellulitis 2.3%
Dehydration 2.3%
Diarrhoea 2.3%

Drug Data